Literature DB >> 179130

mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects.

V Jonsson, A Videbek, N H Axelsen, M Harboe.   

Abstract

A 27-year-old woman with proteinuria and normal serum creatinine for 10 years developed chronic lymphocytic leukaemia (CLL) and after further 2 years during treatment with prednisone and chlorambucil a malignant histiocytoma appeared. Free mu-chains were demonstrated in serum, but it is possible that mu-chain disease (mu-CD) and Bence-Jones proteinuria had persisted unrecognized for 12 years, since vacuolated plasma cells were found when the primary bone marrow smear was re-evaluated and no glomerular disorders were found. The clinical findings from the now 11 known cases of mu-CD are reveiwed and the immunochemical findings are reported ain part II (Axelsen et al 1976). The patient's mother died of acute leukaemia at the age of 24. The mother's sister has mammary carcinoma and several members of the mother's line apparently have increased tendency to infections. Of 27 family members, none exhibited immunoglobulin defects, but 10 members of the mother's line had B- as well as T-lymphocytosis and 5 members had leukocytosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179130     DOI: 10.1111/j.1600-0609.1976.tb01140.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.

Authors:  W Feremans; M Caudron; C Bieva
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

2.  Multiple extranodal tumors in mu-heavy chain disease.

Authors:  Akinori Maeda; Minako Mori; Satoko Torii; Yuya Nagai; Katsuhiro Togami; Haruyuki Fujita; Masayuki Kurata; Akiko Matsushita; Kenichi Nagai; Yukihiro Imai; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.

Authors:  Machi Yanai; Akinori Maeda; Naoko Watanabe; Naoshi Sugimoto; Akiko Matsushita; Kenichi Nagai; Tatsuo Oida; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.